大健康国际2024/25 年度报告

Stock Code: 2211(Incorporated in the Cayman Islands with limited liability ANNUAL REPORT2024/25 Company Profile2Corporate Information4Financial Highlights7Chairman’s Statement8Management Discussion and Analysis12Environmental, Social and Governance Report28Report of the Directors47Corporate Governance Report65Directors and Senior Management88Independent Auditor’s Report97Consolidated Balance Sheet109Consolidated Statement of Comprehensive Income111Consolidated Statement of Changes in Equity113Consolidated Cash Flow Statement115Notes to the Consolidated Financial Statements117Financial Summary251 CONTENTS目錄 COMPANY PROFILE公司簡介 本公司2211本集團+ Universal Health International Group Holding Limited (StockCode: 2211) (the “Company”, together with its subsidiaries, the“Group”) and its subsidiaries aims at huge market opportunitiesin the universal health industry, strives to be international brandoperator of universal health and become a leading practitioner ofthe strategy of “Internet + Universal Health” as well as a pioneerof the development of ecology in the industry chain by way offinance and capital. 中國1201,0278423 The Company is one of the leading pharmaceutical retailers anddistributors in the Northeast of the People’s Republic of China (the“PRC” or “China”). The Group has distinguished pharmaceuticalretail chain network in the Northeast China and it is also the largestprivately operated pharmaceutical distributor in the NortheastChina. As of the date of this annual report, the Group operated120 retail pharmacies, mainly located in the Northeast China,and had approximately 1,027 active distributors and 842 full-timestaff. In addition, the Group has set up 3 large-scale distributionlogistics centers in Shijiazhuang, Harbin and Jiamusi, forming ahigh-quality distribution system that spans the whole country,with strong coverage across the northeastern region of the PRC. As a basic business segment, the Group’s main product categoriesfor pharmaceutical retail and distribution (including import andexport trade) include prescribed drugs, non-prescribed drugs(Chinese patent medicines, chemical preparations, antibioticsand biochemical drugs), traditional Chinese medicine decoctionpieces, biological products, protein assimilation preparations,peptide hormones, blood products, disinfection products, medicalequipment, family planning supplies (contraceptives and utensils),prepackaged foods, dairy products (including infant formula milkpowder), nutritional foods, health care products, stereotypedpackaging cosmetics, daily necessities, etc. The Group will continue leveraging on the core advantagesof branded products, expanding the scope of cooperation onbranded products, leveraging on business institute training, andproviding more value-added service to employees, customersand consumers. The Group also enriches the product mix byintroducing more health care products based on the expertise inpharmaceutical retail and distribution, so as to promote the conceptof the universal health industry. Meanwhile, the Group activelyexplores upstream ecological chain, covering the construction forChinese herbal medicines base. +++ The Group actively explores online pharmacies, cross-bordere-commerce, influencer marketing and other “Internet+” areas,and advocates the concept of “Specialization+” and introducesthe development concept of “Platform+”. Furthermore, the Groupmaintains upstream and downstream ecosystem leveraging onindustry advantage to cope with the situation of “New Norm” inreal economy, and takes the lead in upgrading and digitalizedtransformation of the industry. CORPORATE INFORMATION公司資料 BOARD OF DIRECTORS 董事會 執行董事： Executive Directors: Mr. Chu Chuanfu(Chairman,Chief Executive Officer and Chief Operating Officer)Mr. Jin Dongkun(Vice Chairman)Mr. Zhao Zehua 獨立非執行董事： Independent Non-executive Directors: Mr. Cheng Sheung HingMs. Chiang Su Hui SusieMr. Zou Haiyan 審核委員會 AUDIT COMMITTEE Mr. Zou Haiyan(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie REMUNERATION COMMITTEE 薪酬委員會 Mr. Cheng Sheung Hing(Chairman)Ms. Chiang Su Hui SusieMr. Jin Dongkun NOMINATION COMMITTEE 提名委員會 Mr. Chu Chuanfu(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie 綠色可持續發展委員會 ESG COMMITTEE Mr. Chu Chuanfu(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie AUTHORISED REPRESENTATIVES 授權代表 Mr. Zhao ZehuaMs. Hui Kit Ying 公司秘書 COMPANY SECRETARY Ms. Hui Kit Ying 註冊辦事處 REGISTERED OFFICE PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands HEADQUARTERS 總部 14-1 No. 14-1Bei Yi Zhong RoadTiexi DistrictShenyang CityLiaoning Province, the PRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 香港主要營業地點 19242404 Room 2404, 24th FloorWorld-Wide House19 Des Voeux Road CentralCentralHong Kong 主要股份過戶登記處 PRINCIPAL SHARE REGISTRAR AND TRANSFEROFFICE Maples Fund Services (Cayman) Limited Maples Fund Services (Cayman) Limited PO Box 1093, Boundary HallCricket